GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.
Beyond the Plaque Trap: How Spinal Cord Drugs, Immune Sleep Fixes, and Smart Injections Are Transforming Global Alzheimer’s Care in 2026
Discover the first-week November 2026 Alzheimer's research breakthroughs. Learn how repurposed spinal cord drugs repair DNA, immune cells restore sleep, 5-year CTAD trial data proves longevity, and smart home healthtech supports caregivers.
Unlocking the Brain: Why NeuroDiscovery Matters and Where to Learn More
Neurodiscovery, in its broadest sense, encompasses the multidisciplinary field dedicated to unraveling the mysteries of the nervous system. It’s a vibrant tapestry woven from threads of neuroscience, biology, chemistry, physics, psychology, computer science, and even engineering. This collaborative effort aims to decipher how the brain develops, functions, and changes throughout life,
Brain2Qwerty's Magnetoencephalography (MEG) System: A Paradigm Shift in Neuroscience Research
Neuroscience research has long sought to unravel the intricate workings of the human brain, aiming to understand the neural basis of cognition, behavior, and consciousness. Among the various neuroimaging techniques available, magnetoencephalography (MEG) stands out for its exceptional temporal resolution, offering a millisecond-by-millisecond glimpse into brain activity.
How AI is Tackling Alzheimer's: Inside C-BRAIN and Karyoptosis Research
Discover how artificial intelligence and global research initiatives like the C-BRAIN Consortium are uniting open-source data to fight neurodegenerative diseases, plus how new discoveries like karyoptosis offer fresh hope for Alzheimer's therapies.
The Blood Test "Smoke Detector": How AI Helps Family Doctors Spot Alzheimer’s Early
For decades, the path to an Alzheimer’s diagnosis has been a marathon, not a sprint. Patients and families often face months of uncertainty, navigating a complex web of specialist referrals, expensive PET scans, and invasive spinal taps. This delay is particularly challenging in primary care, where family doctors
Alzheimer’s Breakthrough: Why Tau-Targeting Therapies Are Changing the Game
Explore how tau-targeting drug Diranersen and a newly diversified research pipeline are reshaping Alzheimer's treatment and slowing cognitive decline.